Disulfiram's journey from rubber vulcanization to T-cell activation.
EMBO J
; 41(16): e111862, 2022 08 16.
Article
em En
| MEDLINE
| ID: mdl-35848116
Disulfiram, a drug prescribed for the treatment of alcohol use disorders for more than 60 years, has recently been repurposed for cancer treatment. New work in The EMBO Journal now describes a disulfiram role in immunotherapy of cancer, involving direct binding to Lck to mediate activation of tumor-infiltrating T cells.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Dissuasores de Álcool
/
Alcoolismo
/
Neoplasias
Limite:
Humans
Idioma:
En
Ano de publicação:
2022
Tipo de documento:
Article